Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-04

AUTHORS

David E. Alonzo, Geoff G. Z. Zhang, Deliang Zhou, Yi Gao, Lynne S. Taylor

ABSTRACT

PURPOSE: To investigate the underlying physical processes taking place during dissolution of amorphous pharmaceuticals and correlate them to the observed solution concentration-time profiles. Felodipine and indomethacin were used as model hydrophobic compounds. METHODS: Concentration-time profiles were monitored during dissolution of the model amorphous compounds using in situ fiber-optic ultraviolet spectroscopy. Crystallization of the solid exposed to an aqueous environment was monitored using Raman spectroscopy and/or powder X-ray diffraction. Polarized light microscopy was used to provide qualitative information about crystallization processes. RESULTS: For felodipine, a small extent of supersaturation was generated via dissolution at 25 degrees C but not at 37 degrees C. The amorphous solid was found to crystallize rapidly at both temperatures upon exposure to the dissolution medium. Addition of low concentrations of polymers to the dissolution medium was found to delay crystallization of the amorphous solid, leading to the generation of supersaturated solutions. Amorphous indomethacin did not crystallize as readily in an aqueous environment; hence, dissolution resulted in supersaturated solutions. However, crystallization from these supersaturated solutions was rapid. Polymeric additives were able to retard crystallization from supersaturated solutions of both indomethacin and felodipine for up to 4 h. CONCLUSIONS: The dissolution advantage of amorphous solids can be negated either by crystallization of the amorphous solid on contact with the dissolution medium or through rapid crystallization of the supersaturated solution. Polymeric additives can potentially retard both of these crystallization routes, leading to the generation of supersaturated solutions that can persist for biologically relevant timeframes. More... »

PAGES

608-618

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11095-009-0021-1

DOI

http://dx.doi.org/10.1007/s11095-009-0021-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036468424

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20151181


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crystallization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Felodipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indomethacin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Powder Diffraction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spectrum Analysis, Raman", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "X-Ray Diffraction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Purdue University", 
          "id": "https://www.grid.ac/institutes/grid.169077.e", 
          "name": [
            "Department of Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, 575 Stadium Mall Drive, 47907, West Lafayette, Indiana, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alonzo", 
        "givenName": "David E.", 
        "id": "sg:person.01151007051.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151007051.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417574.4", 
          "name": [
            "Global Pharmaceutical R&D, Abbott Laboratories, 100 Abbott Park Road, 60064, Abbott Park, Illinois, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Geoff G. Z.", 
        "id": "sg:person.0735251307.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735251307.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417574.4", 
          "name": [
            "Global Pharmaceutical Operation, Abbott Laboratories, 100 Park Road, 60064, Abbott, Illinois, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhou", 
        "givenName": "Deliang", 
        "id": "sg:person.01300171166.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300171166.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abbott (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417574.4", 
          "name": [
            "Global Pharmaceutical R&D, Abbott Laboratories, 100 Abbott Park Road, 60064, Abbott Park, Illinois, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gao", 
        "givenName": "Yi", 
        "id": "sg:person.01051477707.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051477707.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Purdue University", 
          "id": "https://www.grid.ac/institutes/grid.169077.e", 
          "name": [
            "Department of Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, 575 Stadium Mall Drive, 47907, West Lafayette, Indiana, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "Lynne S.", 
        "id": "sg:person.0644176621.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644176621.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ejpb.2008.06.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001257929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.29.2675", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006254374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-409x(00)00129-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006677292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.21138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007473412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.10522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008453024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-007-9420-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008632052", 
          "https://doi.org/10.1007/s11095-007-9420-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018906132279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009095860", 
          "https://doi.org/10.1023/a:1018906132279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/js9602711", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009483654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0939-6411(00)00076-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010715816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.20925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010838579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-006-9047-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014411505", 
          "https://doi.org/10.1007/s11095-006-9047-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2008.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014524323"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.20697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015119935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(00)00173-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016269545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1007516718048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017094560", 
          "https://doi.org/10.1023/a:1007516718048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.35.2943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018631636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1012167410376", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024196024", 
          "https://doi.org/10.1023/a:1012167410376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-409x(96)00423-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026263620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.44.2111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028346023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2008.01.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033636957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2005.04.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033769490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03639040500529176", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038195382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-006-9023-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038723796", 
          "https://doi.org/10.1007/s11095-006-9023-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2005.03.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041198525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2003.07.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051214263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2003.07.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051214263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-409x(01)00098-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051226353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.10566", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052334547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-005-4594-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053309088", 
          "https://doi.org/10.1007/s11095-005-4594-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-005-4594-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053309088", 
          "https://doi.org/10.1007/s11095-005-4594-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ac8020856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055070644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/ac8020856", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055070644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/cg0602358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055393758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/cg0602358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055393758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jp983964+", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056129163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jp983964+", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056129163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/la070050i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056151792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/la070050i", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056151792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp800061r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056213938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp800061r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056213938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp8000638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056213940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp8000638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056213940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp800169g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056214001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp800169g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056214001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1063/1.1744688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057807129"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-04", 
    "datePublishedReg": "2010-04-01", 
    "description": "PURPOSE: To investigate the underlying physical processes taking place during dissolution of amorphous pharmaceuticals and correlate them to the observed solution concentration-time profiles. Felodipine and indomethacin were used as model hydrophobic compounds.\nMETHODS: Concentration-time profiles were monitored during dissolution of the model amorphous compounds using in situ fiber-optic ultraviolet spectroscopy. Crystallization of the solid exposed to an aqueous environment was monitored using Raman spectroscopy and/or powder X-ray diffraction. Polarized light microscopy was used to provide qualitative information about crystallization processes.\nRESULTS: For felodipine, a small extent of supersaturation was generated via dissolution at 25 degrees C but not at 37 degrees C. The amorphous solid was found to crystallize rapidly at both temperatures upon exposure to the dissolution medium. Addition of low concentrations of polymers to the dissolution medium was found to delay crystallization of the amorphous solid, leading to the generation of supersaturated solutions. Amorphous indomethacin did not crystallize as readily in an aqueous environment; hence, dissolution resulted in supersaturated solutions. However, crystallization from these supersaturated solutions was rapid. Polymeric additives were able to retard crystallization from supersaturated solutions of both indomethacin and felodipine for up to 4 h.\nCONCLUSIONS: The dissolution advantage of amorphous solids can be negated either by crystallization of the amorphous solid on contact with the dissolution medium or through rapid crystallization of the supersaturated solution. Polymeric additives can potentially retard both of these crystallization routes, leading to the generation of supersaturated solutions that can persist for biologically relevant timeframes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11095-009-0021-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution", 
    "pagination": "608-618", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "adb8afe48fd38c345f8f11f36d3a2d398d8a93a2891e64d271f3478f0e9fd610"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20151181"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11095-009-0021-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036468424"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11095-009-0021-1", 
      "https://app.dimensions.ai/details/publication/pub.1036468424"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89789_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11095-009-0021-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11095-009-0021-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11095-009-0021-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11095-009-0021-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11095-009-0021-1'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      72 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11095-009-0021-1 schema:about N2b00542ed5bf4af29f46c9595044eb3c
2 N69517b49a62443dda0c43b0e552ee79b
3 N805553b5cec942a8bfc50dbf0219ff12
4 Na74cc4d22635463bbdcde3a6e86943f2
5 Nb04fb42d763b4ece85d9ff49596588d8
6 Nc1d8e8d915be4f809f5f0cbe7e0b7027
7 Ne8f5350bde7b43539a7f932243ec800d
8 anzsrc-for:03
9 anzsrc-for:0306
10 schema:author N5665ccdf9d41456da218392477c61d4e
11 schema:citation sg:pub.10.1007/s11095-005-4594-z
12 sg:pub.10.1007/s11095-006-9023-4
13 sg:pub.10.1007/s11095-006-9047-9
14 sg:pub.10.1007/s11095-007-9420-3
15 sg:pub.10.1023/a:1007516718048
16 sg:pub.10.1023/a:1012167410376
17 sg:pub.10.1023/a:1018906132279
18 https://doi.org/10.1002/jps.10522
19 https://doi.org/10.1002/jps.10566
20 https://doi.org/10.1002/jps.20697
21 https://doi.org/10.1002/jps.20925
22 https://doi.org/10.1002/jps.21138
23 https://doi.org/10.1016/j.ejpb.2008.01.007
24 https://doi.org/10.1016/j.ejpb.2008.05.023
25 https://doi.org/10.1016/j.ejpb.2008.06.001
26 https://doi.org/10.1016/j.ejps.2005.03.012
27 https://doi.org/10.1016/j.ejps.2005.04.011
28 https://doi.org/10.1016/j.ijpharm.2003.07.010
29 https://doi.org/10.1016/s0169-409x(00)00129-0
30 https://doi.org/10.1016/s0169-409x(01)00098-9
31 https://doi.org/10.1016/s0169-409x(96)00423-1
32 https://doi.org/10.1016/s0928-0987(00)00173-1
33 https://doi.org/10.1016/s0939-6411(00)00076-x
34 https://doi.org/10.1021/ac8020856
35 https://doi.org/10.1021/cg0602358
36 https://doi.org/10.1021/jp983964+
37 https://doi.org/10.1021/js9602711
38 https://doi.org/10.1021/la070050i
39 https://doi.org/10.1021/mp800061r
40 https://doi.org/10.1021/mp8000638
41 https://doi.org/10.1021/mp800169g
42 https://doi.org/10.1063/1.1744688
43 https://doi.org/10.1080/03639040500529176
44 https://doi.org/10.1248/cpb.29.2675
45 https://doi.org/10.1248/cpb.35.2943
46 https://doi.org/10.1248/cpb.44.2111
47 schema:datePublished 2010-04
48 schema:datePublishedReg 2010-04-01
49 schema:description PURPOSE: To investigate the underlying physical processes taking place during dissolution of amorphous pharmaceuticals and correlate them to the observed solution concentration-time profiles. Felodipine and indomethacin were used as model hydrophobic compounds. METHODS: Concentration-time profiles were monitored during dissolution of the model amorphous compounds using in situ fiber-optic ultraviolet spectroscopy. Crystallization of the solid exposed to an aqueous environment was monitored using Raman spectroscopy and/or powder X-ray diffraction. Polarized light microscopy was used to provide qualitative information about crystallization processes. RESULTS: For felodipine, a small extent of supersaturation was generated via dissolution at 25 degrees C but not at 37 degrees C. The amorphous solid was found to crystallize rapidly at both temperatures upon exposure to the dissolution medium. Addition of low concentrations of polymers to the dissolution medium was found to delay crystallization of the amorphous solid, leading to the generation of supersaturated solutions. Amorphous indomethacin did not crystallize as readily in an aqueous environment; hence, dissolution resulted in supersaturated solutions. However, crystallization from these supersaturated solutions was rapid. Polymeric additives were able to retard crystallization from supersaturated solutions of both indomethacin and felodipine for up to 4 h. CONCLUSIONS: The dissolution advantage of amorphous solids can be negated either by crystallization of the amorphous solid on contact with the dissolution medium or through rapid crystallization of the supersaturated solution. Polymeric additives can potentially retard both of these crystallization routes, leading to the generation of supersaturated solutions that can persist for biologically relevant timeframes.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree false
53 schema:isPartOf N326cb25bd0bc4d27a24f57bb943b1516
54 Nff79a9c8fac246189712b5fc725bd8d7
55 sg:journal.1094644
56 schema:name Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution
57 schema:pagination 608-618
58 schema:productId N00a38f1167a942eba8a42f07fda11edc
59 N657f71570d064c20b5bd891cc814ca8e
60 N6bfc4bbb5a194d60bc985292d2dd33cc
61 Nb86cc1b1f04247f584ee4e689859b53f
62 Ndd2598aa1ecd47dca709bb311412ed36
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036468424
64 https://doi.org/10.1007/s11095-009-0021-1
65 schema:sdDatePublished 2019-04-11T09:51
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher N1ce35b9f8c6446908b9eeb86a4e40656
68 schema:url http://link.springer.com/10.1007%2Fs11095-009-0021-1
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N00a38f1167a942eba8a42f07fda11edc schema:name doi
73 schema:value 10.1007/s11095-009-0021-1
74 rdf:type schema:PropertyValue
75 N18e09158906e40a78ec979eae7fc4e35 rdf:first sg:person.0735251307.80
76 rdf:rest Naaae92d2a4804aaea4c3c933c6adb3f1
77 N1ce35b9f8c6446908b9eeb86a4e40656 schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 N2b00542ed5bf4af29f46c9595044eb3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Crystallization
81 rdf:type schema:DefinedTerm
82 N326cb25bd0bc4d27a24f57bb943b1516 schema:volumeNumber 27
83 rdf:type schema:PublicationVolume
84 N5665ccdf9d41456da218392477c61d4e rdf:first sg:person.01151007051.54
85 rdf:rest N18e09158906e40a78ec979eae7fc4e35
86 N657f71570d064c20b5bd891cc814ca8e schema:name readcube_id
87 schema:value adb8afe48fd38c345f8f11f36d3a2d398d8a93a2891e64d271f3478f0e9fd610
88 rdf:type schema:PropertyValue
89 N69517b49a62443dda0c43b0e552ee79b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Spectrum Analysis, Raman
91 rdf:type schema:DefinedTerm
92 N6bfc4bbb5a194d60bc985292d2dd33cc schema:name dimensions_id
93 schema:value pub.1036468424
94 rdf:type schema:PropertyValue
95 N7c1fe166446a41fdabcf3f9c27b92501 rdf:first sg:person.0644176621.83
96 rdf:rest rdf:nil
97 N805553b5cec942a8bfc50dbf0219ff12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name X-Ray Diffraction
99 rdf:type schema:DefinedTerm
100 N82b9dabd5ed243baa20a4f4865b96fda rdf:first sg:person.01051477707.14
101 rdf:rest N7c1fe166446a41fdabcf3f9c27b92501
102 Na74cc4d22635463bbdcde3a6e86943f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Solubility
104 rdf:type schema:DefinedTerm
105 Naaae92d2a4804aaea4c3c933c6adb3f1 rdf:first sg:person.01300171166.08
106 rdf:rest N82b9dabd5ed243baa20a4f4865b96fda
107 Nb04fb42d763b4ece85d9ff49596588d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Powder Diffraction
109 rdf:type schema:DefinedTerm
110 Nb86cc1b1f04247f584ee4e689859b53f schema:name nlm_unique_id
111 schema:value 8406521
112 rdf:type schema:PropertyValue
113 Nc1d8e8d915be4f809f5f0cbe7e0b7027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Felodipine
115 rdf:type schema:DefinedTerm
116 Ndd2598aa1ecd47dca709bb311412ed36 schema:name pubmed_id
117 schema:value 20151181
118 rdf:type schema:PropertyValue
119 Ne8f5350bde7b43539a7f932243ec800d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Indomethacin
121 rdf:type schema:DefinedTerm
122 Nff79a9c8fac246189712b5fc725bd8d7 schema:issueNumber 4
123 rdf:type schema:PublicationIssue
124 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
125 schema:name Chemical Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
128 schema:name Physical Chemistry (incl. Structural)
129 rdf:type schema:DefinedTerm
130 sg:journal.1094644 schema:issn 0724-8741
131 1573-904X
132 schema:name Pharmaceutical Research
133 rdf:type schema:Periodical
134 sg:person.01051477707.14 schema:affiliation https://www.grid.ac/institutes/grid.417574.4
135 schema:familyName Gao
136 schema:givenName Yi
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051477707.14
138 rdf:type schema:Person
139 sg:person.01151007051.54 schema:affiliation https://www.grid.ac/institutes/grid.169077.e
140 schema:familyName Alonzo
141 schema:givenName David E.
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151007051.54
143 rdf:type schema:Person
144 sg:person.01300171166.08 schema:affiliation https://www.grid.ac/institutes/grid.417574.4
145 schema:familyName Zhou
146 schema:givenName Deliang
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300171166.08
148 rdf:type schema:Person
149 sg:person.0644176621.83 schema:affiliation https://www.grid.ac/institutes/grid.169077.e
150 schema:familyName Taylor
151 schema:givenName Lynne S.
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644176621.83
153 rdf:type schema:Person
154 sg:person.0735251307.80 schema:affiliation https://www.grid.ac/institutes/grid.417574.4
155 schema:familyName Zhang
156 schema:givenName Geoff G. Z.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735251307.80
158 rdf:type schema:Person
159 sg:pub.10.1007/s11095-005-4594-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1053309088
160 https://doi.org/10.1007/s11095-005-4594-z
161 rdf:type schema:CreativeWork
162 sg:pub.10.1007/s11095-006-9023-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038723796
163 https://doi.org/10.1007/s11095-006-9023-4
164 rdf:type schema:CreativeWork
165 sg:pub.10.1007/s11095-006-9047-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014411505
166 https://doi.org/10.1007/s11095-006-9047-9
167 rdf:type schema:CreativeWork
168 sg:pub.10.1007/s11095-007-9420-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008632052
169 https://doi.org/10.1007/s11095-007-9420-3
170 rdf:type schema:CreativeWork
171 sg:pub.10.1023/a:1007516718048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017094560
172 https://doi.org/10.1023/a:1007516718048
173 rdf:type schema:CreativeWork
174 sg:pub.10.1023/a:1012167410376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024196024
175 https://doi.org/10.1023/a:1012167410376
176 rdf:type schema:CreativeWork
177 sg:pub.10.1023/a:1018906132279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009095860
178 https://doi.org/10.1023/a:1018906132279
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1002/jps.10522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008453024
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1002/jps.10566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052334547
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/jps.20697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015119935
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1002/jps.20925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010838579
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/jps.21138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007473412
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ejpb.2008.01.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033636957
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.ejpb.2008.05.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014524323
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.ejpb.2008.06.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001257929
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.ejps.2005.03.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041198525
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.ejps.2005.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033769490
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.ijpharm.2003.07.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051214263
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/s0169-409x(00)00129-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006677292
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0169-409x(01)00098-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051226353
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/s0169-409x(96)00423-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026263620
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0928-0987(00)00173-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016269545
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s0939-6411(00)00076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010715816
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1021/ac8020856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055070644
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1021/cg0602358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055393758
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1021/jp983964+ schema:sameAs https://app.dimensions.ai/details/publication/pub.1056129163
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1021/js9602711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009483654
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1021/la070050i schema:sameAs https://app.dimensions.ai/details/publication/pub.1056151792
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1021/mp800061r schema:sameAs https://app.dimensions.ai/details/publication/pub.1056213938
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1021/mp8000638 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056213940
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1021/mp800169g schema:sameAs https://app.dimensions.ai/details/publication/pub.1056214001
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1063/1.1744688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057807129
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1080/03639040500529176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038195382
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1248/cpb.29.2675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006254374
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1248/cpb.35.2943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018631636
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1248/cpb.44.2111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028346023
237 rdf:type schema:CreativeWork
238 https://www.grid.ac/institutes/grid.169077.e schema:alternateName Purdue University
239 schema:name Department of Industrial and Physical Pharmacy, School of Pharmacy, Purdue University, 575 Stadium Mall Drive, 47907, West Lafayette, Indiana, USA
240 rdf:type schema:Organization
241 https://www.grid.ac/institutes/grid.417574.4 schema:alternateName Abbott (United States)
242 schema:name Global Pharmaceutical Operation, Abbott Laboratories, 100 Park Road, 60064, Abbott, Illinois, USA
243 Global Pharmaceutical R&D, Abbott Laboratories, 100 Abbott Park Road, 60064, Abbott Park, Illinois, USA
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...